Capitalizing on the concept of local immune suppression by inhalation for lung transplant recipients
Year: 2021
Type: editorial
Abstract: A placebo-controlled randomized-trial marked by limited enrollment and early trial termination shows that inhaled cyclosporine, when added to systemic immune suppression for lung transplant recipients, was safe and improved early-in-trial clinical parameters of bronchiolitis obliterans syndrome. See Kneidinger et al. (page 222).
DOI: 10.1111/ajt.16874
Author: Aldo Iacono
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,300
OpenAlex ID: W3208882723
